{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:18:39Z","timestamp":1793319519558,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.urolonc.2020.06.018","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T02:04:34Z","timestamp":1596765874000},"page":"131.e17-131.e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["The combination cytology\/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?"],"prefix":"10.1016","volume":"39","author":[{"given":"Francesco","family":"Pierconti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonia","family":"Cenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Capodimonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Straccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cindolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Maria","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Francesco","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.06.018_bib0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.eururo.2012.09.057","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: screening, diagnosis, and molecular markers","volume":"63","author":"Kamat","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0002","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1464-410X.2006.06036.x","article-title":"Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder","volume":"97","author":"Karakiewicz","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0003","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.eururo.2005.03.014","article-title":"Urine markers for bladder cancer surveillance: A systematic review","volume":"47","author":"van Rhijn","year":"2005","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2020.06.018_bib0004","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000020318","article-title":"Urinary BTA-stat, BTA-trak and NMP22 in surveillance after TUR of recurrent superficial transitional cell carcinoma of the bladder","volume":"38","author":"Serretta","year":"2000","journal-title":"Eur Urol"},{"issue":"6 Suppl 1","key":"10.1016\/j.urolonc.2020.06.018_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2005.08.064","article-title":"Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers","volume":"66","author":"Lokeshwar","year":"2005","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.urolonc.2020.06.018_bib0006","first-page":"400","article-title":"Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt trade mark","volume":"4","author":"Fradet","year":"1997","journal-title":"Can J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2020.06.018_bib0007","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-5347(06)00576-3","article-title":"Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria","volume":"176","author":"Sarosdy","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0008","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bju.14673","article-title":"Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer","volume":"123","author":"D'Andrea","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0009","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","article-title":"Performance of the Bladder EpiCheck Methylation Test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial","volume":"1","author":"Witjes","year":"2018","journal-title":"Eur Urol Oncol."},{"key":"10.1016\/j.urolonc.2020.06.018_bib0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncy.22152","article-title":"Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer","volume":"127","author":"Trenti","year":"2019","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0011","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0012","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cncy.21957","article-title":"The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration","volume":"126","author":"Pierconti","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0013","series-title":"The Paris System for reporting urinary cytology","author":"Rosenthal","year":"2016"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0014","article-title":"PD-L1 expression in bladder primary in situ urothelial carcinoma: Evaluation in BCG-unresponsive patients and BCG responders","author":"Pierconti","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.urolonc.2009.11.004","article-title":"Considerations on implementing diagnostic markers into clinical decision making in bladder cancer","volume":"28","author":"Lotan","year":"2010","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0016","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.urolonc.2010.02.011","article-title":"Statistical consideration for clinical biomarker research in bladder cancer","volume":"28","author":"Shariat","year":"2010","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0017","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.eururo.2007.09.036","article-title":"Challenges of cancer biomarker profiling","volume":"52","author":"Bensalah","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0018","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/cyt.12050","article-title":"Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H)","volume":"25","author":"Piaton","year":"2014","journal-title":"Cytopathology"},{"issue":"7","key":"10.1016\/j.urolonc.2020.06.018_bib0019","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cncy.21278","article-title":"Evaluation of atypical urine cytology progression to malignancy","volume":"121","author":"Muus Ubago","year":"2013","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"10.1016\/j.urolonc.2020.06.018_bib0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0974-7796.68857","article-title":"Diagnostic significance of atypical category in the voided urine samples: A retrospective study in a tertiary care center","volume":"2","author":"Mokhtar","year":"2010","journal-title":"Urol Ann"},{"issue":"5","key":"10.1016\/j.urolonc.2020.06.018_bib0021","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1309\/AJCPPRZLG9KT9AXL","article-title":"Accuracy of urine cytology and the significance of an atypical category","volume":"132","author":"Brimo","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.urolonc.2020.06.018_bib0022","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-6413-3-28","article-title":"Malignant atypical cell in urine cytology: A diagnostic dilemma","volume":"15","author":"Bhatia","year":"2006","journal-title":"Cytojournal"},{"issue":"1","key":"10.1016\/j.urolonc.2020.06.018_bib0023","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/his.13090","article-title":"Iatrogenic changes in the urinary tract","volume":"70","author":"Lopez-Beltran","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2020.06.018_bib0024","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cncy.21957","article-title":"The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration","volume":"126","author":"Pierconti","year":"2018","journal-title":"Cancer Cytopathol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392030288X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392030288X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:19:58Z","timestamp":1761041998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814392030288X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S107814392030288X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.06.018","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combination cytology\/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}